Search alternatives:
significant increased » significant increase (Expand Search), significant increases (Expand Search), significantly increased (Expand Search)
changes decrease » larger decrease (Expand Search), change increases (Expand Search), largest decrease (Expand Search)
increased post » increased costs (Expand Search), increased risk (Expand Search), increased body (Expand Search)
significant increased » significant increase (Expand Search), significant increases (Expand Search), significantly increased (Expand Search)
changes decrease » larger decrease (Expand Search), change increases (Expand Search), largest decrease (Expand Search)
increased post » increased costs (Expand Search), increased risk (Expand Search), increased body (Expand Search)
-
21
-
22
-
23
-
24
-
25
Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.
Published 2025Subjects: -
26
Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.
Published 2025Subjects: -
27
-
28
-
29
-
30
-
31
-
32
Quantification of intensity changes in the contrast generated by Gd in T1 imaging.
Published 2024Subjects: -
33
-
34
-
35
Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.
Published 2025Subjects: -
36
-
37
Delayed treatment with ceftriaxone increases glutamate transporter mRNA in cortex and hippocampus.
Published 2023Subjects: -
38
AZ10606120 treatment significantly increased cytotoxicity and reduced cell number in a dose-dependent manner.
Published 2025“…<b>(b)</b> Cytotoxicity quantified via LDH assay of U251 culture supernatants post-treatment. LDH levels were significantly increased in culture supernatants treated with AZ10606120 (50µM) compared to temozolomide (50µM) treatment and untreated controls. …”
-
39
-
40